Potential inflammatory targets in the integrative health care of patients with sickle cell disease

被引:0
|
作者
Khan, Shahida A. [1 ,2 ]
Halawani, Saeed H. [3 ]
Al Zughaibi, Torki [1 ,2 ]
Khan, Sarah A. [1 ]
机构
[1] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia
[2] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Sci, Jeddah 22252, Saudi Arabia
[3] Umm Al Qura Univ, Fac Med, Dept Hematol & Immunol, Mecca 21955, Saudi Arabia
关键词
inflammation; marker; sickle cell disease; C-REACTIVE PROTEIN; VASOOCCLUSIVE CRISIS; HOMOCYSTEINE LEVEL; CHILDREN; ADOLESCENTS;
D O I
10.3892/etm.2023.12184
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Inflammation plays an integral role in the complications of sickle cell disease (SCD), which can lead to vaso-occlusive crisis and extreme pain. SCD is accompanied by numerous complications, including cardiovascular disease, cognitive decline and endothelial dysfunction, contributing to mortality. As disease severity increases with age, the present study aimed to assess if age is also correlated with a definite pattern of progression of the two inflammatory markers, high-sensitivity C-reactive protein (hsCRP) and total homocysteine (tHCY). The findings of the present study could lead to an improved understanding of the threshold levels of these inflammatory markers and timely interventions to delay complications. In an observational study, levels of hsCRP and tHCY were analyzed in 70 patients (35 male and 35 female patients) with SCD aged between 5 and 16 years. hsCRP levels were in the high-risk range in 64.29% (n=45) of all male and female patients. A sex-wise distribution showed that, of the 35 male patients, 74.28% (n=26) were in the high-risk range, and of the 35 female patients, 54.28% (n=19) were in the high-risk range. An age-wise distribution showed that of the 41 patients in the 5-10-years age group, 70.73% (n=29), were in the high-risk range. In comparison, of the 29 patients in the 11-16-years age group, 55.17% (n=16) were in the high-risk range. tHCY levels were observed to be in the normal range in 98.57% (n=69) of all children, as compared with 1.43% (n=1) in the high-risk range. Furthermore, a sex-wise distribution showed that female patients in the high-risk group of hsCRP had higher concentrations of tHCY as compared with the male patients in that risk group. An age-wise distribution of hsCRP concentration also showed that the risk of CVD in patients in the 11-16-years age group was higher with increased concentrations of tHCY. A weak negative correlation was observed between age and hsCRP concentrations (r-value=-0.280; P=0.026) and a weak positive correlation was detected between tHCY and age (r-value=0.259; P=0.036). In conclusion, the results of the present study indicated that higher levels of hsCRP could be a useful marker in children with SCD, and levels of tHCY may be an adjunct marker as the disease progresses with age.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] A Biopsychosocial Model for the Management of Patients With Sickle-Cell Disease Transitioning to Adult Medical Care
    Crosby, Lori E.
    Quinn, Charles T.
    Kalinyak, Karen A.
    ADVANCES IN THERAPY, 2015, 32 (04) : 293 - 305
  • [22] The Role of Pro-Inflammatory Cytokines in Sickle Cell Disease Saudi Patients
    Tarbiah, Nesrin, I
    Almutairi, Huda S.
    Alkhattabi, Nuha A.
    Zaher, Galila F.
    Alhemadi, Maryam M.
    Alamri, Reema S.
    Sabban, Alia M.
    BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS, 2021, 14 (03): : 1002 - 1007
  • [23] Shared Care for Adults with Sickle Cell Disease: An Analysis of Care from Eight Health Systems
    Mainous, Arch G., III
    Rooks, Benjamin
    Tanner, Rebecca J.
    Carek, Peter J.
    Black, Vandy
    Coates, Thomas D.
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (08)
  • [24] Polymorphisms in Inflammatory Genes Modulate Clinical Complications in Patients With Sickle Cell Disease
    Tozatto-Maio, Karina
    Girot, Robert
    Ly, Indou Deme
    Silva Pinto, Ana Cristina
    Rocha, Vanderson
    Fernandes, Francisco
    Diagne, Ibrahima
    Benzerara, Yahia
    Dinardo, Carla L.
    Soler, Julia Pavan
    Kashima, Simone
    Araujo, Itaua Leston
    Kenzey, Chantal
    Fonseca, Guilherme H. H.
    Rodrigues, Evandra S.
    Volt, Fernanda
    Jarduli, Luciana
    Ruggeri, Annalisa
    Mariaselvam, Christina
    Gualandro, Sandra F. M.
    Rafii, Hanadi
    Cappelli, Barbara
    Nogueira, Felipe Melo
    Scigliuolo, Graziana Maria
    Guerino-Cunha, Renato Luiz
    Malmegrim, Kelen Cristina Ribeiro
    Simoes, Belinda P.
    Gluckman, Eliane
    Tamouza, Ryad
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [25] Sickle cell disease in Grenada: Quality of life and barriers to care
    Grygiel, Alyssa
    Ikolo, Felicia
    Stephen, Raphielle
    Bleasdille, Dawnell
    Robbins-Furman, Patricia
    Nelson, Beverly
    Sobering, Andrew K.
    Elsea, Sarah H.
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2021, 9 (01):
  • [26] Barriers to care and quality of primary care services in children with sickle cell disease
    Jacob, Eufemia
    Childress, Courtney
    Nathanson, Joana Duran
    JOURNAL OF ADVANCED NURSING, 2016, 72 (06) : 1417 - 1429
  • [27] APHON/ASPHO Policy Statement for the Transition of Patients With Sickle Cell Disease From Pediatric to Adult Health Care
    Bryant, Rosalind
    Porter, Jerlym S.
    Sobota, Amy
    JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 2015, 32 (06) : 355 - 359
  • [28] Comprehensive care for patients with sickle cell disease in Cuba
    Fernandez Aguila, J. D.
    Cabrera Zamora, M.
    Alvarez Fernandez, O.
    Prieto Jimenez, L.
    Mediaceja Vicente, O.
    Villares Alvarez, I.
    HAEMATOLOGICA, 2007, 93 (01) : E20 - E20
  • [29] Knowledge and Health Beliefs of Jamaican Adolescents With Sickle Cell Disease
    Bhatt, Komal
    Reid, Marvin E.
    Lewis, Norma A.
    Asnani, Monika R.
    PEDIATRIC BLOOD & CANCER, 2011, 57 (06) : 1044 - 1048
  • [30] Comprehensive care for sickle cell disease immigrant patients: A reproducible model achieving high adherence to minimum standards of care
    Colombatti, Raffaella
    Montanaro, Maria
    Guasti, Fabiola
    Rampazzo, Patrizia
    Meneghetti, Giorgio
    Giordan, Marco
    Basso, Giuseppe
    Sainati, Laura
    PEDIATRIC BLOOD & CANCER, 2012, 59 (07) : 1275 - 1279